These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11160299)

  • 1. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex.
    Carnaud C; Gombert J; Donnars O; Garchon H; Herbelin A
    J Immunol; 2001 Feb; 166(4):2404-11. PubMed ID: 11160299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.
    Poulton LD; Smyth MJ; Hawke CG; Silveira P; Shepherd D; Naidenko OV; Godfrey DI; Baxter AG
    Int Immunol; 2001 Jul; 13(7):887-96. PubMed ID: 11431419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
    Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR
    Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.
    Assarsson E; Kambayashi T; Sandberg JK; Hong S; Taniguchi M; Van Kaer L; Ljunggren HG; Chambers BJ
    J Immunol; 2000 Oct; 165(7):3673-9. PubMed ID: 11034371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
    Kambayashi T; Assarsson E; Michaëlsson J; Berglund P; Diehl AD; Chambers BJ; Ljunggren HG
    J Immunol; 2000 Nov; 165(9):4964-9. PubMed ID: 11046023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
    Slifka MK; Pagarigan RR; Whitton JL
    J Immunol; 2000 Feb; 164(4):2009-15. PubMed ID: 10657652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver.
    Ohteki T; MacDonald HR
    J Exp Med; 1996 Mar; 183(3):1277-82. PubMed ID: 8642272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
    Arase H; Arase N; Saito T
    J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells.
    Carlyle JR; Mesci A; Ljutic B; Belanger S; Tai LH; Rousselle E; Troke AD; Proteau MF; Makrigiannis AP
    J Immunol; 2006 Jun; 176(12):7511-24. PubMed ID: 16751398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation.
    Gadue P; Stein PL
    J Immunol; 2002 Sep; 169(5):2397-406. PubMed ID: 12193707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells.
    Fritz RB; Zhao ML
    J Immunol; 2001 Mar; 166(6):4209-15. PubMed ID: 11238673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.